Daniel Golparian

Artiklar i tidskrifter

• Balthazar, J. T. , Golparian, D. , Unemo, M. , Read, T. D. , Grosse, M. , Stadler, M. , Pfarr, K. , Schiefer, A. & et al. (2024). A laboratory-based predictive pathway for the development of Neisseria gonorrhoeae high-level resistance to corallopyronin A, an inhibitor of bacterial RNA polymerase. Microbiology Spectrum.
• Birhanu, M. , Abegaz, W. E. , Schröder, D. , Mihret, A. , Abebe, T. , Jacobsson, S. , Tasew, G. , Addis, T. & et al. (2024). Antimicrobial susceptibility in Neisseria gonorrhoeae and epidemiological data of gonorrhoea patients in five cities across Ethiopia, 2021-22. JAC-antimicrobial resistance, 6 (1).
• Golparian, d. , Cole, M. J. , Sánchez-Busó, L. , Day, M. , Jacobsson, S. , Uthayakumaran, T. , Abad, R. , Bercot, B. & et al. (2024). Antimicrobial-resistant Neisseria gonorrhoeae in Europe in 2020 compared with in 2013 and 2018: a retrospective genomic surveillance study. The Lancet. Microbe.
• Cordioli, M. , Gios, L. , Erbogasto, A. , Mirandola, M. , Sandri, A. , Padovese, V. , Caceres, C. , Vargas, S. & et al. (2024). Clinic-based evaluation of the dual Xpert CT/NG assay on the GeneXpert System for screening for extragenital chlamydial and gonococcal infections amongst men who have sex with men. BMC Infectious Diseases, 24 (Suppl 1).
• Sangprasert, P. , Golparian, D. , Paopang, P. , Girdthep, N. , Lawung, R. , Gopinath, D. , Thammawijaya, P. , Kittiyaowanarn, R. & et al. (2024). Complete reference genomes of two ceftriaxone-resistant Neisseria gonorrhoeae strains identified in routine surveillance in Bangkok, Thailand, using Nanopore Q20+ chemistry, VolTRAX V2b, and Illumina sequencing. Microbiology Resource Announcements, 13 (3).
• Shephard, M. , Matthews, S. , Kularatne, R. , Andrewartha, K. , Blondeel, K. , Alvarez, C. , Camey, E. , Hançali, A. & et al. (2024). Independent clinic-based evaluation of point-of-care testing for the screening of Chlamydia trachomatis, Neisseria gonorrhoea and Trichomonas vaginalis in women-at-risk in Australia, Guatemala, Morocco, and South Africa. BMC Infectious Diseases, 24 (Suppl 1).
• Unemo, M. , Golparian, D. , Oxelbark, J. , Kong, F. Y. S. , Brown, D. , Louie, A. , Drusano, G. & Jacobsson, S. (2024). Pharmacodynamic evaluation of ceftriaxone single-dose therapy (0.125-1 g) to eradicate ceftriaxone-susceptible and ceftriaxone-resistant Neisseria gonorrhoeae strains in a hollow fibre infection model for gonorrhoea. Journal of Antimicrobial Chemotherapy.
• Sánchez-Busó, L. , Sánchez-Serrano, A. , Golparian, D. & Unemo, M. (2024). pyngoST: fast, simultaneous and accurate multiple sequence typing of Neisseria gonorrhoeae genome collections. Microbial Genomics, 10 (1).
• Golparian, D. , Bazzo, M. L. , Ahlstrand, J. , Schörner, M. A. , Gaspar, P. C. , Machado, H. d. M. , Martins, J. M. , Bigolin, A. & et al. (2024). Recent dynamics in Neisseria gonorrhoeae genomic epidemiology in Brazil: antimicrobial resistance and genomic lineages in 2017-20 compared to 2015-16. Journal of Antimicrobial Chemotherapy.
• Golparian, D. , Jacobsson, S. , Ohnishi, M. & Unemo, M. (2023). Complete Reference Genome Sequence of the Clinical Neisseria gonorrhoeae Strain H035, with Resistance to the Novel Antimicrobial Zoliflodacin, Identified in Japan in 2000. Microbiology Resource Announcements, 12 (3).
• Kakooza, F. , Golparian, D. , Matoga, M. , Maseko, V. , Lamorde, M. , Krysiak, R. , Manabe, Y. C. , Chen, J. S. & et al. (2023). Genomic surveillance and antimicrobial resistance determinants in Neisseria gonorrhoeae isolates from Uganda, Malawi and South Africa, 2015-20. Journal of Antimicrobial Chemotherapy, 78 (8), 1982-1991.
• Golparian, D. , Jacobsson, S. , Holley, C. L. , Shafer, W. M. & Unemo, M. (2023). High-level in vitro resistance to gentamicin acquired in a stepwise manner in Neisseria gonorrhoeae. Journal of Antimicrobial Chemotherapy, 78 (7), 1769-1778.
• Golparian, D. , Vestberg, N. , Södersten, W. , Jacobsson, S. , Ohnishik, M. , Fang, H. , Bhattarai, K. H. & Unemo, M. (2023). Multidrug-resistant Neisseria gonorrhoeae isolate SE690: mosaic penA-60.001 gene causing ceftriaxone resistance internationally has spread to the more antimicrobial- susceptible genomic lineage, Sweden, September 2022. Eurosurveillance, 28 (10).
• Shipitsyna, E. , Kularatne, R. , Golparian, D. , Müller, E. E. , Vargas, S. K. , Hadad, R. , Padovese, V. , Hancali, A. & et al. (2023). Mycoplasma genitalium prevalence, antimicrobial resistance-associated mutations, and coinfections with non-viral sexually transmitted infections in high-risk populations in Guatemala, Malta, Morocco, Peru and South Africa, 2019-2021. Frontiers in Microbiology, 14.
• Jacobsson, S. , Golparian, D. , Oxelbark, J. , Kong, F. Y. , Da Costa, R. M. A. , Franceschi, F. , Brown, D. , Louie, A. & et al. (2023). Pharmacodynamics of zoliflodacin plus doxycycline combination therapy against Neisseria gonorrhoeae in a gonococcal hollow-fiber infection model. Frontiers in Pharmacology, 14.
• Gianecini, R. A. , Poklepovich, T. , Golparian, D. , Cuenca, N. , Scocozza, L. , Bergese, S. , Canigia, L. F. , Vilches, V. & et al. (2023). Sustained Transmission of Neisseria gonorrhoeae Strains with High-Level Azithromycin Resistance (MIC ≥ 256 μg/mL) in Argentina, 2018 to 2022. Microbiology Spectrum, 11 (4).
• Holley, C. L. , Dhulipala, V. , Balthazar, J. T. , Le Van, A. , Begum, A. A. , Chen, S. , Read, T. D. , Matoga, M. & et al. (2022). A Single Amino Acid Substitution in Elongation Factor G Can Confer Low-Level Gentamicin Resistance in Neisseria gonorrhoeae. Antimicrobial Agents and Chemotherapy, 66 (5).
• Berçot, B. , Caméléna, F. , Mérimèche, M. , Jacobsson, S. , Sbaa, G. , Mainardis, M. , Valin, C. , Molina, J. & et al. (2022). Ceftriaxone-resistant, multidrug-resistant Neisseria gonorrhoeae with a novel mosaic penA-237.001 gene, France, June 2022. Eurosurveillance, 27 (50), 17-22.
• Golparian, D. , Pleininger, S. , Jacobsson, S. , Indra, A. & Unemo, M. (2022). Complete Reference Genome Sequence of the Extensively Drug-Resistant Strain Neisseria gonorrhoeae AT159, with Ceftriaxone Resistance and High-Level Azithromycin Resistance, Using Nanopore Q20+ Chemistry and Illumina Sequencing. Microbiology Resource Announcements, 15 (11).
• Sánchez-Busó, L. , Cole, M. J. , Spiteri, G. , Day, M. , Jacobsson, S. , Golparian, D. , Sajedi, N. , Yeats, C. A. & et al. (2022). Europe-wide expansion and eradication of multidrug-resistant Neisseria gonorrhoeae lineages: a genomic surveillance study. The Lancet. Microbe, 3 (6), e452-e463.
• Pleininger, S. , Indra, A. , Golparian, D. , Heger, F. , Schindler, S. , Jacobsson, S. , Heidler, S. & Unemo, M. (2022). Extensively drug-resistant (XDR) Neisseria gonorrhoeae causing possible gonorrhoea treatment failure with ceftriaxone plus azithromycin in Austria, April 2022. Eurosurveillance, 27 (24).
• Hadad, R. , Golparian, D. , Velicko, I. , Ohlsson, A. , Lindroth, Y. , Ericson, E. , Fredlund, H. , Engstrand, L. & et al. (2022). First National Genomic Epidemiological Study of Neisseria gonorrhoeae Strains Spreading Across Sweden in 2016. Frontiers in Microbiology, 12.
• Golparian, D. , Kittiyaowamarn, R. , Paopang, P. , Sangprasert, P. , Sirivongrangson, P. , Franceschi, F. , Jacobsson, S. , Wi, T. & et al. (2022). Genomic surveillance and antimicrobial resistance in Neisseria gonorrhoeae isolates in Bangkok, Thailand in 2018. Journal of Antimicrobial Chemotherapy, 77 (8), 2171-2182.
• Matoga, M. , Chen, J. S. , Krysiak, R. , Ndalama, B. , Massa, C. , Bonongwe, N. , Mathiya, E. , Kamtambe, B. & et al. (2022). Gentamicin susceptibility in Neisseria gonorrhoeae and treatment outcomes for urogenital gonorrhea after twenty-five years of sustained gentamicin use in Malawi. Sexually Transmitted Diseases, 49 (4), 251-256.
• Golparian, D. , Jacobsson, S. , Sánchez-Busó, L. , Bazzo, M. L. , Lan, P. T. , Galarza, P. , Ohnishi, M. & Unemo, M. (2022). GyrB in silico mining in 27 151 global gonococcal genomes from 1928-2021 combined with zoliflodacin in vitro testing of 71 international gonococcal isolates with different GyrB, ParC and ParE substitutions confirms high susceptibility. Journal of Antimicrobial Chemotherapy, 78 (1), 150-154.
• Jacobsson, S. , Golparian, D. , Oxelbark, J. , Wicha, W. W. , da Costa, R. M. A. , Franceschi, F. , Brown, D. , Louie, A. & et al. (2022). Pharmacodynamic evaluation of lefamulin in the treatment of gonorrhea using a hollow fiber infection model simulating Neisseria gonorrhoeae infections. Frontiers in Pharmacology, 13.
• Jacobsson, S. , Golparian, D. , Oxelbark, J. , Franceschi, F. , Brown, D. , Louie, A. , Drusano, G. & Unemo, M. (2022). Pharmacodynamic Evaluation of Zoliflodacin Treatment of Neisseria gonorrhoeae Strains With Amino Acid Substitutions in the Zoliflodacin Target GyrB Using a Dynamic Hollow Fiber Infection Model. Frontiers in Pharmacology, 13.
• Edwards, J. L. , Balthazar, J. T. , Esposito, D. L. A. , Ayala, J. C. , Schiefer, A. , Pfarr, K. , Hoerauf, A. , Alt, S. & et al. (2022). Potent In Vitro and Ex Vivo Anti-Gonococcal Activity of the RpoB Inhibitor Corallopyronin A. mSphere, 7 (5).
• Sánchez-Busó, L. , Yeats, C. A. , Taylor, B. , Goater, R. J. , Underwood, A. , Abudahab, K. , Argimón, S. , Ma, K. C. & et al. (2021). A community-driven resource for genomic epidemiology and antimicrobial resistance prediction of Neisseria gonorrhoeae at Pathogenwatch. Genome Medicine, 13 (1).
• Karymbaeva, S. , Boiko, I. , Jacobsson, S. , Mamaeva, G. , Ibraeva, A. , Usupova, D. , Golparian, D. & Unemo, M. (2021). Antimicrobial resistance and molecular epidemiological typing of Neisseria gonorrhoeae isolates from Kyrgyzstan in Central Asia, 2012 and 2017. BMC Infectious Diseases, 21 (1).
• Aniskevich, A. , Shimanskaya, I. , Boiko, I. , Golubovskaya, T. , Golparian, D. , Stanislavova, I. , Jacobsson, S. , Adaskevich, A. & et al. (2021). Antimicrobial resistance in Neisseria gonorrhoeae isolates and gonorrhoea treatment in the Republic of Belarus, Eastern Europe, 2009-2019. BMC Infectious Diseases, 21 (1).
• Hilmarsdóttir, I. , Arnardóttir, E. M. , Jóhannesdóttir, E. R. , Golparian, D. & Unemo, M. (2021). Chlamydia trachomatis in Iceland: Prevalence, Clinico-epidemiological Features and Comparison of Cobas 480 CT/NG and Aptima Combo 2 (CT/NG) for Diagnosis. Acta Dermato-Venereologica, 101.
• Hadad, R. , Cole, M. J. , Ebeyan, S. , Jacobsson, S. , Tan, L. Y. , Golparian, D. , Erskine, S. , Day, M. & et al. (2021). Evaluation of the SpeeDx ResistancePlus® GC and SpeeDx GC 23S 2611 (beta) molecular assays for prediction of antimicrobial resistance/susceptibility to ciprofloxacin and azithromycin in Neisseria gonorrhoeae. Journal of Antimicrobial Chemotherapy, 76 (1), 84-90.
• Ariel Gianecini, R. , Poklepovich, T. , Golparian, D. , Cuenca, N. , Tuduri, E. , Unemo, M. , Campos, J. & Galarza, P. (2021). Genomic Epidemiology of Azithromycin-Nonsusceptible Neisseria gonorrhoeae, Argentina, 2005-2019. Emerging Infectious Diseases, 27 (9), 2369-2378.
• Unemo, M. , Ahlstrand, J. , Sánchez-Busó, L. , Day, M. , Aanensen, D. , Golparian, D. , Jacobsson, S. & Cole, M. J. (2021). High susceptibility to zoliflodacin and conserved target (GyrB) for zoliflodacin among 1209 consecutive clinical Neisseria gonorrhoeae isolates from 25 European countries, 2018. Journal of Antimicrobial Chemotherapy, 76 (5), 1221-1228.
• Perme, T. , Golparian, D. , Unemo, M. & Jeverica, S. (2021). Lack of diagnostic-escape mutants of Group B Streptococcus in Slovenia. Clinical Microbiology and Infection, 27 (7), 1054-1055.
• Golparian, D. , Sánchez-Busó, L. , Cole, M. & Unemo, M. (2021). Neisseria gonorrhoeae Sequence Typing for Antimicrobial Resistance (NG-STAR) clonal complexes are consistent with genomic phylogeny and provide simple nomenclature, rapid visualization and antimicrobial resistance (AMR) lineage predictions. Journal of Antimicrobial Chemotherapy, 76 (4), 940-944.
• Jacobsson, S. , Golparian, D. , Oxelbark, J. , Alirol, E. , Franceschi, F. , Gustafsson, T. N. , Brown, D. , Louie, A. & et al. (2021). Pharmacodynamic Evaluation of Dosing, Bacterial Kill, and Resistance Suppression for Zoliflodacin Against Neisseria gonorrhoeae  in a Dynamic Hollow Fiber Infection Model. Frontiers in Pharmacology, 12.
• Ma, K. C. , Mortimer, T. D. , Hicks, A. L. , Wheeler, N. E. , Sánchez-Busó, L. , Golparian, D. , Taiaroa, G. , Rubin, D. H. F. & et al. (2020). Adaptation to the cervical environment is associated with increased antibiotic susceptibility in Neisseria gonorrhoeae. Nature Communications, 11 (1).
• Lan, P. T. , Golparian, D. , Ringlander, J. , Van Hung, L. , Van Thuong, N. & Unemo, M. (2020). Genomic analysis and antimicrobial resistance of Neisseria gonorrhoeae isolates from Vietnam in 2011 and 2015-16. Journal of Antimicrobial Chemotherapy, 75 (6), 1432-1438.
• Perme, T. , Golparian, D. , Bombek Ihan, M. , Rojnik, A. , Lučovnik, M. , Kornhauser Cerar, L. , Fister, P. , Lozar Krivec, J. & et al. (2020). Genomic and phenotypic characterisation of invasive neonatal and colonising group B Streptococcus isolates from Slovenia, 2001-2018. BMC Infectious Diseases, 20 (1).
• Boiko, I. , Golparian, D. , Jacobsson, S. , Krynytska, I. , Frankenberg, A. , Shevchenko, T. & Unemo, M. (2020). Genomic epidemiology and antimicrobial resistance determinants of Neisseria gonorrhoeae isolates from Ukraine, 2013-2018. Acta Pathologica, Microbiologica et Immunologica Scandinavica (APMIS), 128 (7), 465-475.
• Golparian, D. , Bazzo, M. L. , Golfetto, L. , Gaspar, P. C. , Schörner, M. A. , Schwartz Benzaken, A. , Ramos, M. C. , Ferreira, W. A. & et al. (2020). Genomic epidemiology of Neisseria gonorrhoeae elucidating the gonococcal antimicrobial resistance and lineages/sublineages across Brazil, 2015-16. Journal of Antimicrobial Chemotherapy, 75 (11), 3163-3172.
• Golparian, D. , Harris, S. R. , Sánchez-Busó, L. , Hoffmann, S. , Shafer, W. M. , Bentley, S. D. , Jensen, J. S. & Unemo, M. (2020). Genomic evolution of Neisseria gonorrhoeae since the preantibiotic era (1928-2013): antimicrobial use/misuse selects for resistance and drives evolution. BMC Genomics, 21 (1).
• Silveira, M. F. , Bruni, M. P. , Stauffert, D. , Golparian, D. & Unemo, M. (2020). Prevalence and risk factors associated with Chlamydia trachomatis, Neisseria gonorrhoeae, and Mycoplasma genitalium among women in Pelotas, Southern Brazil. International Journal of STD and AIDS (London), 31 (5), 432-439.
• Hilmarsdóttir, I. , Arnardóttir, E. M. , Jóhannesdóttir, E. R. , Valsdóttir, F. , Golparian, D. , Hadad, R. , Vigfússon, H. B. & Unemo, M. (2020). Prevalence of Mycoplasma genitalium and antibiotic resistance-associated mutations in an Icelandic STI population, and comparison of the S-DiaMGTV and Aptima Mycoplasma genitalium assays for diagnosis. Journal of Clinical Microbiology, 58 (9).
• Unemo, M. , Hansen, M. , Hadad, R. , Puolakkainen, M. , Westh, H. , Rantakokko-Jalava, K. , Thilesen, C. , Cole, M. J. & et al. (2020). Sensitivity, specificity, inclusivity and exclusivity of the updated Aptima Combo 2 assay, which provides detection coverage of the new diagnostic-escape Chlamydia trachomatis variants. BMC Infectious Diseases, 20 (1).
• Boiko, I. , Golparian, D. , Krynytska, I. , Bezkorovaina, H. , Frankenberg, A. , Onuchyna, M. , Jacobsson, S. & Unemo, M. (2019). Antimicrobial susceptibility of Neisseria gonorrhoeae isolates and treatment of gonorrhoea patients in Ternopil and Dnipropetrovsk regions of Ukraine, 2013-2018. Acta Pathologica, Microbiologica et Immunologica Scandinavica (APMIS), 127 (7), 503-509.
• Bruni, M. P. , Freitas da Silveira, M. , Stauffert, D. , Bicca, G. L. d. O. , Caetano Dos Santos, C. , da Rosa Farias, N. A. , Golparian, D. & Unemo, M. (2019). Aptima Trichomonas vaginalis assay elucidates significant underdiagnosis of trichomoniasis among women in Brazil according to an observational study. Sexually Transmitted Infections, 95 (2), 129-132.
• Sánchez-Busó, L. , Golparian, D. , Parkhill, J. , Unemo, M. & Harris, S. R. (2019). Genetic variation regulates the activation and specificity of Restriction-Modification systems in Neisseria gonorrhoeae. Scientific Reports, 9 (1).
• Gianecini, R. A. , Golparian, D. , Zittermann, S. , Litvik, A. , Gonzalez, S. , Oviedo, C. , Melano, R. G. , Unemo, M. & et al. (2019). Genome-based epidemiology and antimicrobial resistance determinants of Neisseria gonorrhoeae isolates with decreased susceptibility and resistance to extended-spectrum cephalosporins in Argentina in 2011-16. Journal of Antimicrobial Chemotherapy, 74 (6), 1551-1559.
• Boiko, I. , Golparian, D. , Krynsytska, I. & Unemo, M. (2019). High prevalence of Chlamydia trachomatis, Neisseria gonorrhoeae and particularly Trichomonas vaginalis diagnosed using US FDA-approved Aptima molecular tests and evaluation of conventional routine diagnostic tests in Ternopil, Ukraine. Acta Pathologica, Microbiologica et Immunologica Scandinavica (APMIS), 127 (9), 627-634.
• Foerster, S. , Drusano, G. , Golparian, D. , Neely, M. , Piddock, L. J. V. , Alirol, E. & Unemo, M. (2019). In vitro antimicrobial combination testing of and evolution of resistance to the first-in-class spiropyrimidinetrione zoliflodacin combined with six therapeutically relevant antimicrobials for Neisseria gonorrhoeae. Journal of Antimicrobial Chemotherapy, 74 (12), 3521-3529.
• Sánchez-Busó, L. , Golparian, D. , Corander, J. , Grad, Y. H. , Ohnishi, M. , Flemming, R. , Parkhill, J. , Bentley, S. D. & et al. (2019). The impact of antimicrobials on gonococcal evolution. Nature Microbiology, 4 (11), 1941-1950.
• Ryan, L. , Golparian, D. , Fennelly, N. , Rose, L. , Walsh, P. , Lawlor, B. , Mac Aogáin, M. , Unemo, M. & et al. (2018). Antimicrobial resistance and molecular epidemiology using whole-genome sequencing of Neisseria gonorrhoeae in Ireland, 2014-2016: focus on extended-spectrum cephalosporins and azithromycin. European Journal of Clinical Microbiology and Infectious Diseases, 37 (9), 1661-1672.
• Golparian, D. , Donà, V. , Sánchez-Busó, L. , Foerster, S. , Harris, S. , Endimiani, A. , Low, N. & Unemo, M. (2018). Antimicrobial resistance prediction and phylogenetic analysis of Neisseria gonorrhoeae isolates using the Oxford Nanopore MinION sequencer. Scientific Reports, 8 (1).
• Unemo, M. , Salado-Rasmussen, K. , Hansen, M. , Olsen, A. O. , Falk, M. , Golparian, D. , Aasterød, M. , Ringlander, J. & et al. (2018). Clinical and analytical evaluation of the new Aptima Mycoplasma genitalium assay, with data on M. genitalium prevalence and antimicrobial resistance in M. genitalium in Denmark, Norway and Sweden in 2016. Clinical Microbiology and Infection, 24 (5), 533-539.
• Eyre, D. W. , Sanderson, N. D. , Lord, E. , Regisford-Reimmer, N. , Chau, K. , Barker, L. , Morgan, M. , Newnham, R. & et al. (2018). Gonorrhoea treatment failure caused by a Neisseria gonorrhoeae strain with combined ceftriaxone and high-level azithromycin resistance, England, February 2018. Eurosurveillance, 23 (27), 2-7.
• Jönsson, A. , Foerster, S. , Golparian, D. , Hamasuna, R. , Jacobsson, S. , Lindberg, M. , Jensen, J. S. , Ohnishi, M. & et al. (2018). In vitro activity and time-kill curve analysis of sitafloxacin against a global panel of antimicrobial-resistant and multidrug-resistant Neisseria gonorrhoeae isolates. Acta Pathologica, Microbiologica et Immunologica Scandinavica (APMIS), 126 (1), 29-37.
• Jacobsson, S. , Golparian, D. , Scangarella-Oman, N. & Unemo, M. (2018). In vitro activity of the novel triazaacenaphthylene gepotidacin (GSK2140944) against MDR Neisseria gonorrhoeae. Journal of Antimicrobial Chemotherapy, 73 (8), 2072-2077.
• Hadad, R. , Golparian, D. , Lagos, A. C. , Ljungberg, J. , Nilsson, P. , Jensen, J. S. , Fredlund, H. & Unemo, M. (2018). Macrolide and fluoroquinolone resistance in Mycoplasma genitalium in two Swedish counties, 2011-2015. Acta Pathologica, Microbiologica et Immunologica Scandinavica (APMIS), 126 (2), 123-127.
• Golparian, D. , Rose, L. , Lynam, A. , Mohamed, A. , Bercot, B. , Ohnishi, M. , Crowley, B. & Unemo, M. (2018). Multidrug-resistant Neisseria gonorrhoeae isolate, belonging to the internationally spreading Japanese FC428 clone, with ceftriaxone resistance and intermediate resistance to azithromycin, Ireland, August 2018. Eurosurveillance, 23 (47), 6-9.
• Harris, S. R. , Cole, M. J. , Spiteri, G. , Sanchez-Buso, L. , Golparian, D. , Jacobsson, S. , Goater, R. , Abudahab, K. & et al. (2018). Public health surveillance of multidrug-resistant clones of Neisseria gonorrhoeae in Europe: a genomic survey. The Lancet - Infectious diseases, 18 (7), 758-768.
• Jacobsson, S. , Boiko, I. , Golparian, D. , Blondeel, K. , Kiarie, J. , Toskin, I. , Peeling, R. W. & Unemo, M. (2018). WHO laboratory validation of Xpert((R)) CT/NG and Xpert((R)) TV on the GeneXpert system verifies high performances. Acta Pathologica, Microbiologica et Immunologica Scandinavica (APMIS), 126 (12), 907-912.
• Jacobsson, S. , Paukner, S. , Golparian, D. , Jensen, J. S. & Unemo, M. (2017). In Vitro Activity of the Novel Pleuromutilin Lefamulin (BC-3781) and Effect of Efflux Pump Inactivation on Multidrug-Resistant and Extensively Drug-Resistant Neisseria gonorrhoeae. Antimicrobial Agents and Chemotherapy, 61 (11).
• Shipitsyna, E. , Rumyantseva, T. , Golparian, D. , Khayrullina, G. , Lagos, A. C. , Edelstein, I. , Joers, K. , Jensen, J. S. & et al. (2017). Prevalence of macrolide and fluoroquinolone resistance-mediating mutations in Mycoplasma genitalium in five cities in Russia and Estonia. PLOS ONE, 12 (4).
• Donà, V. , Low, N. , Golparian, D. & Unemo, M. (2017). Recent advances in the development and use of molecular tests to predict antimicrobial resistance in Neisseria gonorrhoeae. Expert Review of Molecular Diagnostics, 17 (9), 845-859.
• Serwin, A. B. , Bulhak-Koziol, V. , Sokolowska, M. , Golparian, D. & Unemo, M. (2017). Trichomonas vaginalis is very rare among women with vaginal discharge in Podlaskie province, Poland. Acta Pathologica, Microbiologica et Immunologica Scandinavica (APMIS), 125 (9), 840-843.
• Fifer, H. , Natarajan, U. , Jones, L. , Alexander, S. , Hughes, G. , Golparian, D. & Unemo, M. (2016). Failure of Dual Antimicrobial Therapy in Treatment of Gonorrhea. New England Journal of Medicine, 374 (25), 2504-2506.
• Unemo, M. , Golparian, D. , Sánchez-Busó, L. , Grad, Y. , Jacobsson, S. , Ohnishi, M. , Lahra, M. M. , Limnios, A. & et al. (2016). The novel 2016 WHO Neisseria gonorrhoeae reference strains for global quality assurance of laboratory investigations: phenotypic, genetic and reference genome characterization. Journal of Antimicrobial Chemotherapy, 71 (11), 3096-3108.
• Jacobsson, S. , Golparian, D. , Cole, M. , Spiteri, G. , Martin, I. , Bergheim, T. , Borrego, M. J. , Crowley, B. & et al. (2016). WGS analysis and molecular resistance mechanisms of azithromycin-resistant (MIC >2 mg/L) Neisseria gonorrhoeae isolates in Europe from 2009 to 2014. Journal of Antimicrobial Chemotherapy, 71 (11), 3109-3116.
• Golparian, D. , Hellmark, B. & Unemo, M. (2015). Analytical specificity and sensitivity of the novel dual-target GeneProof Neisseria gonorrhoeae PCR kit for detection of N-gonorrhoeae. Acta Pathologica, Microbiologica et Immunologica Scandinavica (APMIS), 123 (11), 955-958.
• Lebedzeu, F. , Golparian, D. , Titov, L. , Pankratava, N. , Glazkova, S. , Shimanskaya, I. , Charniakova, N. , Lukyanau, A. & et al. (2015). Antimicrobial susceptibility/resistance and NG-MAST characterisation of Neisseria gonorrhoeae in Belarus, Eastern Europe, 2010-2013. BMC Infectious Diseases, 15.
• Rumyantseva, T. , Golparian, D. , Nilsson, C. S. , Johansson, E. , Falk, M. , Fredlund, H. , Van Dam, A. , Guschin, A. & et al. (2015). Evaluation of the new AmpliSens multiplex real-time PCR assay for simultaneous detection of Neisseriagonorrhoeae, Chlamydiatrachomatis, Mycoplasmagenitalium, and Trichomonasvaginalis. Acta Pathologica, Microbiologica et Immunologica Scandinavica (APMIS), 123 (10), 879-886.
• Golparian, D. , Boräng, S. , Sundqvist, M. & Unemo, M. (2015). Evaluation of the New BD Max GC Real-Time PCR Assay, Analytically and Clinically as a Supplementary Test for the BD ProbeTec GC Qx Amplified DNA Assay, for Molecular Detection of Neisseria gonorrhoeae. Journal of Clinical Microbiology, 53 (12), 3935-3937.
• Foerster, S. , Golparian, D. , Jacobsson, S. , Hathaway, L. J. , Low, N. , Shafer, W. M. , Althaus, C. L. & Unemo, M. (2015). Genetic Resistance Determinants, In Vitro Time-Kill Curve Analysis and Pharmacodynamic Functions for the Novel Topoisomerase II Inhibitor ETX0914 (AZD0914) in Neisseria gonorrhoeae. Frontiers in Microbiology, 6.
• Pellrud, H. , Golparian, D. , Nilsson, C. S. , Falk, M. , Fredlund, H. & Unemo, M. (2015). Trichomonas vaginalis Infections are Rare Among Young Patients Attending an STI Clinic in Sweden. Acta Dermato-Venereologica, 95 (3), 343-344.
• Golparian, D. & Unemo, M. (2015). Will Genome Analysis Elucidate Evolution, Global Transmission and Virulence of Neisseria Meningitidis Lineages?. EBioMedicine, 2 (3), 186-187.
• Mlynarczyk-Bonikowska, B. , Serwin, A. B. , Golparian, D. , de Walthoffen, S. W. , Majewski, S. , Koper, M. , Malejczyk, M. , Domeika, M. & et al. (2014). Antimicrobial susceptibility/resistance and genetic characteristics of Neisseria gonorrhoeae isolates from Poland, 2010-2012. BMC Infectious Diseases, 14.
• Unemo, M. , Golparian, D. & Shafer, W. M. (2014). Challenges with gonorrhea in the era of multi-drug and extensively drug resistance -are we on the right track?. Expert Review of Anti-Infective Therapy, 12 (6), 653-656.
• Muhammad, I. , Golparian, D. , Dillon, J. R. , Johansson, Å. , Ohnishi, M. , Sethi, S. , Chen, S. , Nakayama, S. & et al. (2014). Characterisation of blaTEM genes and types of β-lactamase plasmids in Neisseria gonorrhoeae - the prevalent and conserved blaTEM-135 has not recently evolved and existed in the Toronto plasmid from the origin. BMC Infectious Diseases, 14 (1).
• Unemo, M. , Golparian, D. & Hellmark, B. (2014). First Three Neisseria gonorrhoeae Isolates with High-Level Resistance to Azithromycin in Sweden: a Threat to Currently Available Dual-Antimicrobial Regimens for Treatment of Gonorrhea?. Antimicrobial Agents and Chemotherapy, 58 (1), 624-625.
• Golparian, D. , Ohlsson, A. K. , Janson, H. , Lidbrink, P. , Richtner, T. , Ekelund, O. , Fredlund, H. & Unemo, M. (2014). Four treatment failures of pharyngeal gonorrhoea with ceftriaxone (500 mg) or cefotaxime (500 mg), Sweden, 2013 and 2014. Eurosurveillance, 19 (30), 2-5.
• Jeverica, S. , Golparian, D. , Hanzelka, B. , Fowlie, A. J. , Maticic, M. & Unemo, M. (2014). High in vitro activity of a novel dual bacterial topoisomerase inhibitor of the ATPase activities of GyrB and ParE (VT12-008911) against Neisseria gonorrhoeae isolates with various high-level antimicrobial resistance and multidrug resistance. Journal of Antimicrobial Chemotherapy, 69 (7), 1866-1872.
• Jacobsson, S. , Golparian, D. , Alm, R. A. , Huband, M. , Mueller, J. , Jensen, J. S. , Ohnishi, M. & Unemo, M. (2014). High In Vitro Activity of the Novel Spiropyrimidinetrione AZD0914, a DNA Gyrase Inhibitor, against Multidrug-Resistant Neisseria gonorrhoeae Isolates Suggests a New Effective Option for Oral Treatment of Gonorrhea. Antimicrobial Agents and Chemotherapy, 58 (9), 5585-5588.
• Golparian, D. , Shafer, W. M. , Ohnishi, M. & Unemo, M. (2014). Importance of Multidrug Efflux Pumps in the Antimicrobial Resistance Property of Clinical Multidrug-Resistant Isolates of Neisseria gonorrhoeae. Antimicrobial Agents and Chemotherapy, 58 (6), 3556-3559.
• Jeverica, S. , Golparian, D. , Maticic, M. , Potocnik, M. , Mlakar, B. & Unemo, M. (2014). Phenotypic and molecular characterization of Neisseria gonorrhoeae isolates from Slovenia, 2006-12: rise and fall of the multidrug-resistant NG-MAST genogroup 1407 clone?. Journal of Antimicrobial Chemotherapy, 69 (6), 1517-1525.
• van Dam, A. P. , van Ogtrop, M. L. , Golparian, D. , Mehrtens, J. , de Vries, H. J. C. & Unemo, M. (2014). Verified clinical failure with cefotaxime 1g for treatment of gonorrhoea in the Netherlands: a case report. Sexually Transmitted Infections, 90 (7), 513-514.
• Tabrizi, S. N. , Unemo, M. , Golparian, D. , Twin, J. , Limnios, A. E. , Lahra, M. & Guy, R. (2013). Analytical Evaluation of GeneXpert CT/NG, the First Genetic Point-of-Care Assay for Simultaneous Detection of Neisseria gonorrhoeae and Chlamydia trachomatis. Journal of Clinical Microbiology, 51 (6), 1945-1947.
• Golparian, D. , Tabrizi, S. N. & Unemo, M. (2013). Analytical Specificity and Sensitivity of the APTIMA Combo 2 and APTIMA GC Assays for Detection of Commensal Neisseria Species and Neisseria gonorrhoeae on the Gen-Probe Panther Instrument. Sexually Transmitted Diseases, 40 (2), 175-178.
• Sethi, S. , Golparian, D. , Bala, M. , Dorji, D. , Ibrahim, M. , Jabeen, K. & Unemo, M. (2013). Antimicrobial susceptibility and genetic characteristics of Neisseria gonorrhoeae isolates from India, Pakistan and Bhutan in 2007-2011. BMC Infectious Diseases, 13.
• Olsen, B. , Thi Lan, P. , Golparian, D. , Johansson, E. , Khang, T. H. & Unemo, M. (2013). Antimicrobial susceptibility and genetic characteristics of Neisseria gonorrhoeae isolates from Vietnam, 2011. BMC Infectious Diseases, 13 (1).
• Ison, C. A. , Golparian, D. , Saunders, P. , Chisholm, S. & Unemo, M. (2013). Evolution of Neisseria gonorrhoeae is a continuing challenge for molecular detection of gonorrhoea: false negative gonococcal porA mutants are spreading internationally. Sexually Transmitted Infections, 89 (3), 197-201.
• Unemo, M. , Golparian, D. , Skogen, V. , Olsen, A. O. , Moi, H. , Syversen, G. & Hjelmevoll, S. O. (2013). Neisseria gonorrhoeae Strain with High-Level Resistance to Spectinomycin Due to a Novel Resistance Mechanism (Mutated Ribosomal Protein S5) Verified in Norway. Antimicrobial Agents and Chemotherapy, 57 (2), 1057-1061.
• Lewis, D. A. , Sriruttan, C. , Mueller, E. E. , Golparian, D. , Gumede, L. , Fick, D. , de Wet, J. , Maseko, V. & et al. (2013). Phenotypic and genetic characterization of the first two cases of extended-spectrum-cephalosporin-resistant Neisseria gonorrhoeae infection in South Africa and association with cefixime treatment failure. Journal of Antimicrobial Chemotherapy, 68 (6), 1267-1270.
• Seth-Smith, H. M. B. , Harris, S. R. , Skilton, R. J. , Radebe, F. M. , Golparian, D. , Shipitsyna, E. , Duy, P. T. , Scott, P. & et al. (2013). Whole-genome sequences of Chlamydia trachomatis directly from clinical samples without culture. Genome Research, 23 (5), 855-866.
• Golparian, D. , Johansson, E. & Unemo, M. (2012). Clinical Neisseria gonorrhoeae isolate with a N. meningitidis porA gene and no prolyliminopeptidase activity, Sweden, 2011-danger of false-negative genetic and culture diagnostic results. Eurosurveillance, 17 (9), 5-7.
• Heymans, R. , Bruisten, S. M. , Golparian, D. , Unemo, M. , de Vries, H. J. C. & van Dam, A. P. (2012). Clonally Related Neisseria gonorrhoeae Isolates with Decreased Susceptibility to the Extended-Spectrum Cephalosporin Cefotaxime in Amsterdam, the Netherlands. Antimicrobial Agents and Chemotherapy, 56 (3), 1516-1522.
• Heymans, R. , Golparian, D. , Bruisten, S. M. , Schouls, L. M. & Unemo, M. (2012). Evaluation of Neisseria gonorrhoeae Multiple-Locus Variable-Number Tandem-Repeat Analysis, N. gonorrhoeae Multiantigen Sequence Typing, and Full-Length porB Gene Sequence Analysis for Molecular Epidemiological Typing. Journal of Clinical Microbiology, 50 (1), 180-183.
• Hess, D. , Wu, A. , Golparian, D. , Esmaili, S. , Pandori, W. , Sena, E. , Klausner, J. D. , Barry, P. & et al. (2012). Genome Sequencing of a Neisseria gonorrhoeae Isolate of a Successful International Clone with Decreased Susceptibility and Resistance to Extended-Spectrum Cephalosporins. Antimicrobial Agents and Chemotherapy, 56 (11), 5633-5641.
• Golparian, D. , Fernandes, P. , Ohnishi, M. , Jensen, J. S. & Unemo, M. (2012). In vitro activity of the new fluoroketolide solithromycin (CEM-101) against a large collection of clinical Neisseria gonorrhoeae isolates and international reference strains, including those with high-level antimicrobial resistance: potential treatment option for gonorrhea?. Antimicrobial Agents and Chemotherapy, 56 (5), 2739-2742.

Artiklar, forskningsöversikter

• Kakooza, F. , Kiggundu, R. , Mboowa, G. , Kateete, P. D. , Nsangi, O. T. , Kabahita, J. M. , Ssentalo Bagaya, B. , Golparian, D. & et al. (2023). Antimicrobial susceptibility surveillance and antimicrobial resistance in Neisseria gonorrhoeae in Africa from 2001 to 2020: A mini-review. Frontiers in Microbiology, 14.
• Golparian, D. & Unemo, M. (2022). Antimicrobial resistance prediction in Neisseria gonorrhoeae: Current status and future prospects. Expert Review of Molecular Diagnostics, 22 (1), 29-48.

Konferensbidrag

• Manjate, A. , Andersson, S. , Golparian, D. , Kenga, D. , Langa, J. , Passanduca, A. , Relvas, V. , Sacarlal, J. & et al. (2024). Assessment of the performance of a multiplex real-time PCR, AmpliSens Florocenosis/Bacterial Vaginosis-FRT, versus Nugent's criteria in the diagnosis of BV in women in Mozambique. I:  Sexually Transmitted Diseases. Konferensbidrag vid Annual Meeting of the Infectious-Diseases-Society-for-Obstetrics-and-Gynecology (IDSOG), Boston, MA, USA, August 4-6, 2022. (ss. S433-S434). Lippincott Williams & Wilkins.
• Jacobsson, S. , Golparian, D. , Oxelbark, J. , Aliro, E. , Franceschi, F. , Gustafsson, T. , Brown, D. , Louie, A. & et al. (2022). Pharmacodynamic evaluation of zoliflodacin dosing,bacterial kill and resistance suppression in Neisseria gonorrhoeae using a dynamichollow fiber infection model.  Konferensbidrag vid 22nd International Pathogenic Neisseria Conference Lagoon Beach Hotel, Cape Town, South Africa, 9-14 Oct, 2022.
• Hadad, R. , Golparian, D. , Velicko, I. , Lindroth, Y. , Ohlsson, A. , Fredlund, H. & Unemo, M. (2021). GENOMIC EPIDEMIOLOGY OF NEISSERIA GONORRHOEAE ISOLATES IN SWEDEN-2016 NATIONAL STUDY. I:  Sexually Transmitted Infections. Konferensbidrag vid STI & HIV World Congress, July 14–17, 2021. (ss. A135-A135). BMJ Publishing Group Ltd.
• Foerster, S. , Drusano, G. , Golparian, D. , Neely, M. , Piddock, L. , Alirol, E. & Unemo, M. (2019). IN VITRO COMBINATION TESTING AND SELECTION OF RESISTANCE TO ZOLIFLODACIN COMBINED WITH SIX ANTIMICROBIALS FOR N. GONORRHOEAE. I:  Sexually Transmitted Infections. BMJ Publishing Group Ltd.
• Seth-Smith, H. , Egli-Gany, D. , Golparian, D. , Dona, V. , Endimiani, A. , Unemo, M. & Low, N. (2019). NEISSERIA GONORRHOEAE GENOMIC DIVERSITY IN HIGH RISK GROUPS IN SWITZERLAND. I:  Sexually Transmitted Infections. BMJ Publishing Group Ltd.